期刊文献+

补肾生髓益智汤联合甘露特钠胶囊治疗老年髓海不足型阿尔茨海默病痴呆临床研究

Clinical Study on Bushen Shengsui Yizhi Decoction Combined with Sodium Oligomannate Capsules for Senile Dementia Caused by Alzheimer's Disease of Insufficiency in Sea of Marrow Type
下载PDF
导出
摘要 目的:观察补肾生髓益智汤联合甘露特钠胶囊治疗老年髓海不足型阿尔茨海默病痴呆的临床疗效。方法:选取124例老年髓海不足型阿尔茨海默病痴呆进行研究,按照随机数字表法分为治疗组与对照组各62例。治疗组给予补肾生髓益智汤联合甘露特钠胶囊治疗,对照组给予甘露特钠胶囊治疗。比较2组临床疗效,以及治疗前后简易精神状态量表(MMSE)、阿尔茨海默病评定量表-认知部分(ADAS-cog)、长谷川痴呆量表(HDS)、痴呆行为量表(BEHAVE-AD)评分。结果:治疗后,治疗组总有效率为90.32%,对照组为75.81%。2组比较,差异有统计学意义(P<0.05)。治疗后,2组MMSE评分均较治疗前上升(P<0.05),且治疗组MMSE评分高于对照组(P<0.05);2组ADAS-cog评分均较治疗前下降(P<0.05),且治疗组ADAS-cog评分低于对照组(P<0.05)。治疗后,2组HDS评分均较治疗前上升(P<0.05),且治疗组HDS评分高于对照组(P<0.05);2组BEHAVE-AD评分均较治疗前下降(P<0.05),且治疗组BEHAVE-AD评分低于对照组(P<0.05)。结论:补肾生髓益智汤联合甘露特钠胶囊治疗老年髓海不足型阿尔茨海默病痴呆临床疗效良好,可改善患者认知功能及痴呆症状。 Objective:To observe the clinical effect of Bushen Shengsui Yizhi Decoction combined with Sodium Oligomannate Capsules on senile dementia caused by Alzheimer's disease of insufficiency in the sea of marrow type.Methods:A total of 124 cases of patients with Alzheimer's disease of insufficiency in the sea of marrow type were selected and divided into the treatment group and the control group according to the random number table method,with 62 cases in each group.The treatment group was treated with Bushen Shengsui Yizhi Decoction combined with Sodium Oligomannate Capsules,and the control group was treated with Sodium Oligomannate Capsules.The scores of Mini-Mental State Examination(MMSE),the Alzheimer's Disease Assessment Scale-Cognitive Subscale(ADAS-Cog),Hasegawa's Dementia Scale(HDS),and Behavioral Pathology in Alzheimer's Disease(BEHAVE-AD)scale before and after treatment,as well as clinical effects were compared between the two groups.Results:After treatment,the total effective rate was 90.32%in the treatment group and 75.81%in the control group,the difference being significant(P<0.05).After treatment,MMSE scores in the two groups were increased when compared with those before treatment(P<0.05),and MMSE score in the treatment group was higher than that in the control group(P<0.05);ADAS-cog scores in the two groups were decreased when compared with those before treatment(P<0.05),and ADAS-cog score in the treatment group was lower than that in the control group(P<0.05).After treatment,HDS scores in the two groups were increased when compared with those before treatment(P<0.05),and HDS score in the treatment group was higher than that in the control group(P<0.05);BEHAVE-AD scores in the two groups were decreased when compared with those before treatment(P<0.05),and BEHAVE-AD score in the treatment group was lower than that in the control group(P<0.05).Conclusion:Bushen Shengsui Yizhi Decoction combined with Sodium Oligomannate Capsules has good clinical effects in the treatment of senile dementia caused by Alzheimer's disease of insufficiency in the sea of marrow type and can improve cognitive and dementia symptoms.
作者 潘亚平 沈校康 魏红辉 孙宁宁 PAN Yaping;SHEN Xiaokang;WEI Honghui;SUN Ningning(Department of Geriatrics,Tongde Hospital of Zhejiang Province,Hangzhou Zhejiang 311122,China;Department of Rehabilitation,Tongde Hospital of Zhejiang Province,Hangzhou Zhejiang 311122,China)
出处 《新中医》 CAS 2024年第10期73-76,共4页 New Chinese Medicine
基金 浙江省医药卫生科技计划项目(2023KY626)。
关键词 阿尔茨海默病 痴呆 髓海不足型 补肾生髓益智汤 甘露特钠胶囊 长谷川痴呆量表 痴呆行为量表 Alzheimer's disease Dementia Insufficiency in the sea of marrow type Bushen Shengsui Yizhi Decoction Sodium Oligomannate Capsules Hasegawa's Dementia Scale Behavioral Pathology in Alzheimer's Disease
  • 相关文献

参考文献10

二级参考文献71

  • 1郑琴,罗俊,章德林,唐宇,朱梅芳,汤丹丰,吴海霞,郭园园.基于糖代谢、脂代谢和能量代谢探讨脾脏与阿尔茨海默病的关系[J].中国实验方剂学杂志,2020,0(5):178-185. 被引量:16
  • 2徐采利(综述),罗涛,汪华侨(审阅).肠道菌群在阿尔茨海默病发病机制和治疗的影响[J].解剖学研究,2020(2):177-180. 被引量:4
  • 3烟建华.《内经》“神”概念研究[J].河南中医,2006,26(1):4-8. 被引量:36
  • 4Wang HL,Yu X,Li SR,et al. The cognitive subscale of Alzheimer's disease assessment scale, Chinese version in staging of Alzheimer disease. Alzheimer Dis Assoc Diisord, 2004,18(4) : 231-235.
  • 5Rosen WG,Mohs RC,Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry, 1984,141 : 1356 - 1364.
  • 6Folstein MF, Folstein SE, McHugh PR. Mini-mental state : A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 1975,12: 189-195.
  • 7Cummings JL. The neuropsychiatric inventory:Assessing psychopathology in dementia patients. Neurology, 1997,48 (6):S10-S16.
  • 8Murali Doraiswamy P,Lee K,Florian B,Robert LG. The Alzheimer's desease assessment scale : Evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimerys disease. Alzheimer Disease and Associated Disorders, 2001,15(4): 174-183.
  • 9Baron M, Jimenez EA, Orensonz L, Gobernado JM. The Alzheimer's disease assessment scale:To the editor. American Academy of Neurology, 1998,50:1516.
  • 10Chu LW, Chiu KC, Hui SL,et al. The reliability and validity of the Alzheimer's desease assessment scale cognitive subscale (ADAS-Cog) among the elderly Chinese in Hong Kong. Ann Acad Med Singapore, 2000,29(4) : 474-485.

共引文献333

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部